Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Common Stock Valuation Ratios
- Price to FCFE (P/FCFE)
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
- Current Ratio
- Over the observed periods, the current ratio demonstrates a fluctuating yet generally stable trend around the range of 1.6 to 1.85. Initially, there was a gradual increase from 1.75 to a peak of 2.01 by mid-2022, indicating an improvement in short-term liquidity and a stronger buffer of current assets over current liabilities. However, this was followed by a decline towards the end of 2022 reaching approximately 1.63, suggesting a reduction in liquidity. In subsequent quarters, the ratio oscillated moderately, ending near 1.7 by the latest period, which reflects a maintained but somewhat cautious liquidity position.
- Quick Ratio
- The quick ratio exhibits a somewhat similar oscillating pattern but remains consistently lower than the current ratio, reflecting the exclusion of inventory from liquid assets. Starting at 1.16, the ratio improved to around 1.33 by mid-2022, suggesting enhanced ability to meet short-term obligations without relying on inventory sales. Thereafter, there was a noticeable drop to close to 1.00 by late 2022 and sustaining slightly above that level with some minor fluctuations around 1.00 to 1.14. This indicates a relatively steady but slightly weakened immediate liquidity position compared to its peak.
- Cash Ratio
- The cash ratio shows the most variability and the lowest absolute values among the liquidity measures, ranging from 0.47 to 0.78. Initially, there was a healthy increase from 0.67 to about 0.78 up to the end of 2021, signaling growing cash and cash equivalents relative to current liabilities. However, a decline followed through 2023 and into 2024, bottoming near 0.47, indicating reduced cash availability compared to short-term liabilities. Subsequent quarters show minor recoveries and stabilization around 0.53 to 0.56, suggesting cautious management of highly liquid assets but with less liquidity cushion than the other ratios.
- Overall Analysis
- Across the three liquidity ratios, the data indicates an initial strengthening of liquidity positions up to mid-2022, followed by a period of contraction and relative stabilization at slightly lower levels. The current ratio remains the highest, highlighting a generally satisfactory level of current asset coverage of liabilities. The quick ratio maintains a moderate margin, while the cash ratio points to more conservative cash reserves relative to obligations. This pattern suggests a strategic balance between liquidity maintenance and possibly more efficient asset utilization or shifts in working capital composition over time.
Current Ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Current assets | |||||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Current ratio1 | |||||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
1 Q3 2025 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
- Current Assets
- The current assets exhibit a generally stable pattern over the observed periods, fluctuating within a moderate range. Starting from approximately 21,817 million US dollars, the value steadily increased to around 25,224 million by the end of 2022. Subsequent quarters show a minor decline and oscillation, with values varying from roughly 22,376 million to 24,839 million in early 2025. Overall, current assets maintain a consistent level with no significant long-term upward or downward trend.
- Current Liabilities
- Current liabilities demonstrate more volatility compared to current assets. They rose steadily from 12,462 million US dollars in early 2021 to a notable peak of 15,489 million by the end of 2022. Following this peak, liabilities decreased and fluctuated between approximately 13,004 million and 14,902 million through 2024 and early 2025, before slightly increasing again to around 14,582 million. This indicates periods of heightened short-term obligations, particularly toward late 2022, which subsequently eased somewhat.
- Current Ratio
- The current ratio shows a pattern of relative stability with minor fluctuations. It started at 1.75 in the first quarter of 2021, displayed an increasing trend reaching 2.01 by mid-2022, suggesting improved liquidity during this period. However, it declined sharply to 1.63 by the end of 2022, reflecting a temporary reduction in short-term financial strength. Post-2022, the ratio stabilized around the 1.6 to 1.8 range, concluding near 1.7 in early 2025. Despite these fluctuations, the ratio remains above the critical threshold of 1, indicating that current assets consistently exceed current liabilities.
Quick Ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||||
| Short-term investments | |||||||||||||||||||||||||
| Trade receivables, less allowances | |||||||||||||||||||||||||
| Total quick assets | |||||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Quick ratio1 | |||||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
1 Q3 2025 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The financial data reveals varied trends in liquidity over the observed periods. The total quick assets demonstrate fluctuations with an overall moderate growth trajectory punctuated by occasional declines. Initially, quick assets rose from approximately 14,468 million US dollars to peak at around 16,736 million by the end of 2021, followed by a dip in early 2023 and mid-2024 before stabilizing and finally increasing toward the end of the period to approximately 15,871 million.
Current liabilities exhibit a generally increasing pattern, with some periods of decline. Starting at nearly 12,462 million US dollars, current liabilities rose steadily to reach a peak of about 15,489 million at the end of 2022. Subsequently, the liabilities decreased notably in 2023 but experienced variability throughout 2024 and 2025, ending with values just below the prior peak level at roughly 14,582 million.
The quick ratio, representing the relationship between quick assets and current liabilities, reflects the interplay between these two elements. The ratio began slightly above 1.1, showing an improvement through 2021 to a peak ratio of 1.33 in mid-2022, indicating strong short-term liquidity during that period. Thereafter, the quick ratio declined notably, falling below 1.0 in early 2024, which suggests moments when quick assets were insufficient to cover current liabilities. The ratio recovered marginally afterward, oscillating around 1.0 to 1.14 toward the later periods, indicating a return to more balanced liquidity but with less buffer compared to earlier peaks.
Overall, the data suggests that while quick assets tend to follow a growth trend, the increase in current liabilities has exerted pressure on short-term liquidity. The quick ratio's movement below and near 1.0 in some quarters highlights potential liquidity constraints that may warrant close monitoring. The periods of peak liquidity ratio correlate with times when quick assets outpaced growth in liabilities, reflecting periods of stronger financial flexibility.
- Total Quick Assets
- Generally increasing with fluctuations; peaked in late 2021 and stabilized with moderate growth toward 2025.
- Current Liabilities
- Overall upward trend with peaks in late 2022; periods of decline followed by renewed variability in 2024 and 2025.
- Quick Ratio
- Peaked mid-2022 above 1.3 indicating strong liquidity; declined to near or below 1.0 in early 2024, indicating tighter liquidity; recovered slightly subsequently.
These observations imply that liquidity management will be crucial moving forward as the company experiences fluctuations in both quick assets and current liabilities, with periodic pressures on the short-term ability to meet obligations.
Cash Ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||||
| Short-term investments | |||||||||||||||||||||||||
| Total cash assets | |||||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Cash ratio1 | |||||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
1 Q3 2025 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The financial data reveals several noteworthy trends in liquidity and short-term financial management over the examined periods.
- Total cash assets
- Total cash assets exhibited a fluctuating pattern throughout the periods. Initially, there was a steady increase from early 2021 until the end of 2021, peaking at over 10 billion US dollars. This was followed by a decline in the first quarter of 2022, but the assets rebounded somewhat by the end of 2022. In 2023, cash assets generally decreased, reaching their lowest point in the third quarter before a slight recovery towards the year's end. The first half of 2024 showed a modest increase again, followed by some variability but trending slightly downward towards early 2025. Overall, there is a volatility in cash assets with no sustained upward or downward trend across the entire period.
- Current liabilities
- Current liabilities generally trended upwards over the timeframe. Beginning at approximately 12.5 billion US dollars in early 2021, liabilities saw a gradual increase throughout 2021 and 2022, with a significant spike by the end of 2022 reaching nearly 15.5 billion. In 2023, there was some fluctuation, but liabilities remained elevated compared to 2021, hovering mostly between 13 and 14.5 billion. Into 2024 and early 2025, liabilities showed some volatility but exhibited an overall persistence at high levels relative to earlier periods.
- Cash ratio
- The cash ratio, which measures the ability to cover current liabilities with cash assets, shows a downward trend over time. The ratio started near 0.67 in early 2021, increasing slightly to peak at approximately 0.78 by the end of 2021. Thereafter, a marked decline occurred, dropping to around 0.53 by the end of 2023 and fluctuating between 0.47 and 0.56 through 2024 and into 2025. This decline indicates a weakening liquidity position, with cash assets increasingly insufficient relative to current liabilities.
In summary, while total cash assets have been volatile without a consistent growth trajectory, current liabilities have generally increased, leading to a steady decline in the cash ratio. This trend suggests growing short-term financial obligations relative to liquid cash reserves, potentially signaling increased liquidity risk which may warrant closer management attention going forward.